▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3787 by analyst upside · 2026-06-27
TBRG
TruBridge, Inc.
Healthcare · Market Cap $393M · P/E 90.3x
ANALYST PRICE TARGET
-2.9%
implied upside to consensus target
Current Price $26.2
Consensus Target $25.44
Bull Target $26.25
Bear Target $23.0
Analysts Covering 4
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
1
Hold
3
Sell
0
52-Week Low $13.88
52-Week High $26.51
YTD Return +25.4%
FUNDAMENTALS
Market Cap $393M
P/E Ratio (TTM) 90.3x
Forward P/E 8.9x
EPS (TTM) $0.29
PEG Ratio 0.32
Dividend Yield N/A
Revenue (TTM) $346M
Profit Margin 1.3%
52-WEEK RANGE
52-Week Low $13.88
52-Week High $26.51
Current Price $26.2
Bear Target $23.0
Bull Target $26.25
● Now $26.2 ● Target $25.44
TRADING DATA
Avg Volume 320K
YTD Return +25.4%
Analyst Count 4
Consensus Hold
Upside to Target -2.9%
Last Updated 2026-06-27

ANALYST SUMMARY

TruBridge, Inc. (TBRG) is currently trading at $26.2 with a Wall Street consensus price target of $25.44, which is 2.9% below the current price over the next 12 months. 4 analysts currently cover TBRG, with a consensus rating of Hold - 25% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $26.25, while the most cautious has a target of $23.0.

TBRG operates in the Healthcare sector with a market capitalisation of $393M. The stock is up 25.4% year-to-date and is currently trading near the upper end of its 52-week range of $13.88 – $26.51.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

NRC +10.5%
NRC Health
$469M · P/E 52.0x · Strong Buy
ELMD -2.7%
Electromed, Inc.
$343M · P/E 35.4x · Buy
CYH +1.0%
Community Health Systems, Inc.
$462M · P/E 0.9x · Hold
HSTM +19.7%
HealthStream, Inc.
$781M · P/E 38.2x · Buy
BVS +51.3%
Bioventus Inc.
$663M · P/E 23.9x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for TBRG, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Cantor Fitzgerald ↓ Downgrade
Overweight → Neutral 2026-04-24 40% win rate (10 calls)
Freedom Capital Markets ↓ Downgrade
Buy → Hold 2026-04-24 Building track record
Stephens & Co. — Reiterated
Equal-Weight → Equal-Weight 2026-04-01 Building track record
Stephens & Co. reit
Equal-Weight → Equal-Weight 2025-04-10 Building track record
Stephens & Co. — Reiterated
Equal-Weight → Equal-Weight 2025-03-11 Building track record
Cantor Fitzgerald — Reiterated
Overweight → Overweight 2025-03-11 40% win rate (10 calls)
Stephens & Co. — Reiterated
Equal-Weight → Equal-Weight 2024-11-20 Building track record
Barclays — Reiterated
Equal-Weight → Equal-Weight 2024-11-11 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
12/30
Consensus clarity
28/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →